Relative bioavailability trial to investigate the pharmacokinetics of tapentadol following the administration of 3 prototype tapentadol 25 mg prolonged release (PR) granule formulations compared to a Palexia PR 25 mg tablet in healthy adult subjects.

Trial Profile

Relative bioavailability trial to investigate the pharmacokinetics of tapentadol following the administration of 3 prototype tapentadol 25 mg prolonged release (PR) granule formulations compared to a Palexia PR 25 mg tablet in healthy adult subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Jul 2015

At a glance

  • Drugs Tapentadol (Primary) ; Tapentadol
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors Grunenthal
  • Most Recent Events

    • 04 Jul 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
    • 19 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top